Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Aclaris Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- +13 vs. Q2 2022
- Shares held
- 63.6M
- +335.8K (+0.5%) vs. Q2 2022
- Total value
- $1.00B
- +$117.8M (+13.3%) vs. Q2 2022
- New holders
- 19
- 48 more added
- Sold out
- 6
- 26 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aisling Capital Management LP | 634,455 | $9.99M | 6.63% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 696,171 | $11.0M | 2.56% | 00.0% | Unchanged |
| Woodline Partners LP | 697,007 | $11.0M | 0.16% | +75,450+12.1% | Added |
| Adage Capital Partners GP, L.L.C. | 700,000 | $11.0M | 0.03% | +75,000+12.0% | Added |
| Vivo Capital, LLC | 898,631 | $14.1M | 1.56% | 00.0% | Unchanged |
| Great Point Partners LLC | 1,019,282 | $16.0M | 3.86% | −63,718−5.9% | Reduced |
| Geode Capital Management, LLC | 1,028,723 | $16.2M | 0.00% | +71,507+7.5% | Added |
| Citadel Advisors LLC | 1,118,417 | $17.6M | 0.02% | +165,345+17.3% | Added |
| TCG Crossover Management, LLC | 1,144,939 | $18.0M | 5.41% | 00.0% | Unchanged |
| FMR LLC | 1,145,339 | $18.0M | 0.00% | −96,969−7.8% | Reduced |
| Deutsche Bank AG | 1,168,897 | $18.4M | 0.01% | −5,804−0.5% | Reduced |
| Renaissance Technologies LLC | 1,185,178 | $18.7M | 0.03% | −144,500−10.9% | Reduced |
| Foresite Capital Management V, LLC | 1,258,243 | $19.8M | 15.23% | 00.0% | Unchanged |
| State Street Corp | 1,303,027 | $20.5M | 0.00% | +72,786+5.9% | Added |
| Laurion Capital Management LP | 1,304,624 | $20.5M | 0.57% | −135,451−9.4% | Reduced |
| Point72 Asset Management, L.P. | 1,853,251 | $29.2M | 0.13% | +119,351+6.9% | Added |
| Holocene Advisors, LP | 2,060,918 | $32.4M | 0.21% | 00.0% | Unchanged |
| Commodore Capital LP | 2,410,622 | $37.9M | 6.10% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,758,434 | $43.4M | 0.86% | +432,934+18.6% | Added |
| Foresite Capital Management IV, LLC | 2,808,034 | $44.2M | 14.21% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,931,709 | $46.1M | 0.00% | +118,024+4.2% | Added |
| Wellington Management Group LLP | 3,453,853 | $54.4M | 0.01% | −1,447,410−29.5% | Reduced |
| Rock Springs Capital Management LP | 3,961,249 | $62.4M | 1.61% | +34,100+0.9% | Added |
| BVF Inc | 3,976,543 | $62.6M | 2.59% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,398,453 | $69.2M | 1.48% | 00.0% | Unchanged |
| VR Adviser, LLC | 4,563,962 | $71.8M | 11.08% | 00.0% | Unchanged |
| BlackRock Inc. | 4,810,298 | $75.7M | 0.00% | +140,382+3.0% | Added |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −12,090−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −11,799−100.0% | Sold out |
| Telemetry Investments, L.L.C. | 0 | $0 | 0.00% | −11,043−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| HighPoint Advisor Group LLC | – | – | – | – | Not filed |